At this time, posts about Celltrion Healthcare are rapidly increasing on portals and stock communities. Today, foreigners have net purchased 62,000 shares of Celltrion Healthcare, while institutions have net sold 11,000 shares, according to preliminary data. Celltrion Healthcare is known as the exclusive distributor of biosimilars for Celltrion.


As of 12:31 PM on the 29th, the stock price of Celltrion Healthcare rose 7.75% from the previous day to 169,600 KRW, with a trading volume of 5,690,359 shares, which is about 87.96% of the 5-day average trading volume.


In addition to Celltrion Healthcare, posts by investors are also surging for Maxstrotech (141070), L&K Bio (156100), and Solbon (035610).



※Source: AI Investment Assistant AI Lassi


※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing